Majoon Jograj Guggul: Exploring Novel Scientific Horizons in Unani Therapeutics
Abstract
Majoon Jograj Guggul is a renowned polyherbal preparation of the Unani system that has traditionally been prescribed for a variety of musculoskeletal disorders, neurological conditions, and long-standing inflammatory diseases. Classical Unani scholars have described the formulation as possessing Muhallil-e-Waram (anti-inflammatory), Musakkin-e-Alam (pain-relieving), Muqawwi-e-Asab (nervine strengthening), and Muqawwi-e-Mafasil (joint-supportive) properties The formulation is centered on Guggul (Commiphora mukul) and is supplemented with several medicinal plant ingredients that act collectively to enhance its therapeutic effectiveness. Scientific investigations conducted in recent years have provided evidence supporting many of its traditional claims. Research indicates that the bioactive compounds present in the formulation, particularly guggulsterones, flavonoids, terpenoids, and various phenolic constituents, contribute to a broad spectrum of pharmacological effects, including anti-inflammatory, antioxidant, anti-arthritic, neuroprotective, immunomodulatory, and lipid-lowering activities. The present review explores the traditional therapeutic significance, phytochemical composition, and pharmacological potential of Majoon Jograj Guggul while examining the scientific evidence behind its emerging clinical applications. By bridging classical Unani principles with contemporary biomedical research, this review underscores the value of scientifically validating traditional formulations and highlights their potential role in modern healthcare and future therapeutic research.
Keywords: Majoon Jograj Guggul, Unani Medicine, Commiphora mukul, Anti-inflammatory, Arthritis, Neuroprotective, Polyherbal formulation, Evidence-based medicine.
Keywords:
Majoon Jograj Guggul, Unani Medicine, Commiphora mukul, Anti-inflammatory, Arthritis, Neuroprotective, Polyherbal formulation, Evidence-based medicineDOI
https://doi.org/10.22270/jddt.v16i8.7924References
1. Ahmad SI, et al. Introduction to Al Umoor Al Tabiya. New Delhi: Saini Printers; 2008.
2. Anonymous. National Formulary of Unani Medicine. Part I. New Delhi: Ministry of AYUSH, Government of India; 2006.
3. Ibn Sina. Al-Qanoon fit Tib (Canon of Medicine). Urdu translation by Ghulam Hasnain Kantoori. New Delhi: Idara Kitab-us-Shifa.
4. Khan MA. Muheet-e-Azam. Vols. 1–4. New Delhi: Central Council for Research in Unani Medicine; 2013.
5. Singh BB, Mishra LC, Vinjamury SP, et al. The effectiveness of Commiphora mukul for osteoarthritis of the knee: An outcomes study. Alternative Therapies in Health and Medicine. 2003;9(3):74–79.
6. Central Council for Research in Unani Medicine. Majoon-e-Jograj Gugal. New Delhi: Ministry of AYUSH, Government of India. Accessed May 29, 2026.
7. Bimbima. Unani Medicine Majun Jograj Gugal. Published November 25, 2016. Accessed May 29, 2026.
8. Rabbani Unani. Majoon-e-Jograj Gugal New Shama (125 g). Accessed May 29, 2026.
9. Kirtikar KR, Basu BD. Indian Medicinal Plants. 2nd ed. Dehradun: International Book Distributors; 2006.
10. Nadkarni AK. Dr. K. M. Nadkarni's Indian Materia Medica. 3rd ed. Mumbai: Popular Prakashan; 2009.
11. Wallis TE. Textbook of Pharmacognosy. 5th Ed. New Delhi: CBS Publishers & Distributors; 2005.
12. Shishodia S, Aggarwal BB. Guggulsterone inhibits NF-κB activation induced by carcinogens and inflammatory stimuli. Cancer Research. 2004; 64:5004–5012.
13. Meselhy MR. Inhibition of LPS-induced NO production by the oleogum resin of Commiphora wightii and its constituents. Phytochemistry. 2003; 62:213–218.
14. Kabiruddin M. Makhzan-ul-Mufradat. New Delhi: Idara Kitab-us-Shifa; 2007.
15. Sharma JN, et al. Anti-inflammatory activity of herbal formulations. Indian Journal of Pharmacology. 2011; 43:123–128.
16. Kokate CK, Purohit AP, Gokhale SB. Pharmacognosy. Pune: Nirali Prakashan; 2010.
17. Gilani AH, Rahman AU. Trends in ethnopharmacology. Journal of Ethnopharmacology. 2005; 100:43–49.
18. Urizar NL, Moore DD. Guggulipid: A natural cholesterol-lowering agent. Annual Review of Nutrition. 2003; 23:303–313.
19. Azmi AA. Advia-e-Mufrada. New Delhi: Qaumi Council Baraye Farogh Urdu Zaban; 2012.
20. Szapary PO, Wolfe ML, Bloedon LT, Cucchiara AJ, DerMarderosian AH, Cirigliano MD, Rader DJ. Guggulipid for the treatment of hypercholesterolemia: A randomized controlled trial. JAMA. 2003;290(6):765–772. https://doi.org/10.1001/jama.290.6.765
21. Ulbricht C, Basch E, Szapary P, Hammerness P, Axentsev S, Boon H, Kroll D, Garraway L, Vora M, Woods J, Costa D. Guggul for hyperlipidemia: A review by the Natural Standard Research Collaboration. Complementary Therapies in Medicine. 2005;13(4):279–290. https://doi.org/10.1016/j.ctim.2005.03.003.
Published
Abstract Display: 55 
PDF Downloads: 53 PDF Downloads: 13 How to Cite
Issue
Section
Copyright (c) 2026 Abid Nadeem Nomani , Birjis Fatma , Jamal Akhtar , Shah Alam
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.